中国科学院大连化学物理研究所机构知识库
Advanced  
DICP OpenIR  > 中国科学院大连化学物理研究所  > 会议论文
学科主题: 物理化学
题名: Time Dependent Inhibition Of CYP3A4 Was The Potent Reason For High-Frequency Clinical Drug-Drug Interaction Of Erlotinib
作者: Dong PP(董佩佩) ;  Fang ZZ(房中则) ;  Zhang YY(张延延) ;  Ge GB(葛广波) ;  Mao YX(毛玉玺) ;  Zhu LL(朱亮亮) ;  Li W(李巍) ;  Yang L(杨凌)
会议名称: 18th International Symposium on Microsomes and Drug Oxidations
会议日期: 2010-5-16
出版日期: 2010-05-16
会议地点: 中国
通讯作者: Ling Yang
部门归属: 十八室
主办者: Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College
摘要: Background: To expain the high frenquency drug-drug interactions of erlotinib, the inhibition potential and kinetic information of erlotinib to seven CYP isoforms was investigated. Meanwhile the in vivo drug-drug interaction magnitude was extrapolated from in vitro data. The activities of seven CYP isoforms (CYP3A4, CYP1A2, CYP2A6, CYP2E1, CYP2D6, CYP2C9, CYP2C8) in human liver microsomes were investigated following co- or pre-incubation with erlotinib. A two-step incubation method was used to examine in vitro TDI of erlotinib. Reversible and TDI prediction equations were employed to extrapolate in vivo drug-drug interaction magnitude from in vitro data. Results: Among seven CYP isoforms tested, the activities of CYP3A4 and CYP2C8 were inhibited with an IC50 of 31.8±7.7 μM and 6.17±1.8 μM. Kinetic analysis showed that inhibition of CYP3A4 and CYP2C8 by erlotinib was best fit to a competitive manner with Ki value of 20.8 μM and 6.2μM. Erlotinib also exhibited TDI to CYP3A4. The inactivation parameters (KI and kinact) were calculated to be 19.0 μM and 0.18 min-1. For three different doses of erlotinib (50,100,150 mg/day), the AUC of coadministered drugs was predicted to increase 0.8%, 0.9% and 1.5% using unbound portal vein concentration with reversible inhibition prediction equation for CYP3A4. As for CYP2C8, the increasement of AUC was predicted to be 2.7%, 3.2% and 5.3%. With TDI prediction equation for three different doses for CYP3A4, the AUC was estimated to increase by 8.98~467.5%, 9.9~868.1% and 10.2~1268.0 using unbound systemic concentration for fm from 0.1 to 1 separately. Conclusions: TDI of erlotinib potentially explains the high-frequency clinical drug-drug interaction of erlotinib. Attentions should be payed when the drugs which are mainly cleared by CYP3A4 were coadminstered with erlotinib.
语种: 中文
内容类型: 会议论文
URI标识: http://cas-ir.dicp.ac.cn/handle/321008/114062
Appears in Collections:中国科学院大连化学物理研究所_会议论文

Files in This Item:

There are no files associated with this item.


Recommended Citation:
Dong PP,Fang ZZ,Zhang YY,et al. Time Dependent Inhibition Of CYP3A4 Was The Potent Reason For High-Frequency Clinical Drug-Drug Interaction Of Erlotinib[C]. 见:18th International Symposium on Microsomes and Drug Oxidations. 中国. 2010-5-16.
Service
 Recommend this item
 Sava as my favorate item
 Show this item's statistics
 Export Endnote File
Google Scholar
 Similar articles in Google Scholar
 [董佩佩]'s Articles
 [房中则]'s Articles
 [张延延]'s Articles
CSDL cross search
 Similar articles in CSDL Cross Search
 [董佩佩]‘s Articles
 [房中则]‘s Articles
 [张延延]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
  Add to CiteULike  Add to Connotea  Add to Del.icio.us  Add to Digg  Add to Reddit 
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Powered by CSpace